Clinical Updates
Evolution and Future Frontiers of PCSK9 Inhibition: From Genetic Discovery to Genomic Medicine
By MedXY|Mar 25, 2026
This review synthesizes the trajectory of PCSK9 inhibitors, from pivotal monoclonal antibody trials to emerging RNA interference and gene-editing technologies, emphasizing their role in achieving ultra-low LDL-C levels and reducing major ad
